PMDD has three subtypes based on symptom timing, Uppsala study finds

Premenstrual dysphoric disorder (PMDD), a severe mood condition linked to the menstrual cycle, does not follow one single pattern but falls into three distinct subtypes, according to a study from Uppsala University in Sweden published in the journal Nature Communications and reported on Tuesday, 10 November 2026. The team, led by Erika Comasco, a professor of molecular psychiatry at Uppsala, analysed daily symptom diaries kept by 90 women with PMDD over two menstrual cycles and compared them with women without significant premenstrual symptoms. They found that symptoms differ mainly in when they start, when they peak and how severe they become.

PMDD is a severe premenstrual mood disorder, well beyond the milder premenstrual syndrome, or PMS, that many women know. Because it returns every cycle, it can shape a woman's work, studies and relationships month after month, which is why it belongs in any honest discussion of work-life balance.

The new study's main contribution is to show that "PMDD" is not one uniform experience. A woman whose symptoms start two weeks before her period lives with the condition for much longer each month than one whose symptoms rise only in the last few days. The researchers hope that recognising these subtypes will eventually lead to more individualised treatment, matched to each woman's pattern. They are careful about the limits: Comasco has said the work cannot explain why these differences occur, and the team says more research is needed before the patterns can be used to predict how PMDD will develop in an individual. The next step, they say, is to see whether the subtypes are linked to differences in brain function and in how women respond to treatment.

The study also underlines the value of tracking symptoms day by day. A published review notes that standardised two-month prospective symptom tracking gives a more reliable estimate of PMDD than recall alone. In other words, the diary method the Uppsala team used is also the method doctors rely on to tell PMDD apart from other mood conditions.

For Indian readers, the numbers are uncertain. An Indian study of young women in a tertiary hospital in eastern India cites a very wide range of prevalence estimates from Indian research, from 3.7% to 65.7%, and its authors attribute the spread to differences in social and cultural factors and in the diagnostic tools used. Such a range shows how little settled data exists, and how much depends on how the condition is measured. This is general information about a study, not medical advice; anyone whose premenstrual symptoms seriously disrupt daily life should speak to a qualified doctor.

Peepals calculation: Using the timings the researchers reported, the build-up from first symptoms to peak lasts about nine days in the severe early-onset group (from about 14 days before a period to about 5 days before), about ten days in the severe late-onset group (from about 10 days before to the start of menstruation) and about six days in the moderate late-onset group (from 10 days before to 4 days before). Our calculation from the reported figures.

Short-term: The findings give women and clinicians a clearer vocabulary for describing different PMDD experiences, and may encourage careful daily symptom tracking.

Long-term: If later studies link the subtypes to brain function or treatment response, care for PMDD could become more personalised. Workplaces and families may also gain a better understanding of why the condition affects women so differently.

Who is affected: Women and girls who live with severe premenstrual mood symptoms, their families and employers, and doctors and researchers working on menstrual and mental health.

What to watch next: The researchers say their next step is to examine whether the three subtypes relate to differences in brain function and treatment response.

Questions and Answers